These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25998621)

  • 1. Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review).
    Schirrmacher V
    Int J Mol Med; 2015 Jul; 36(1):3-10. PubMed ID: 25998621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus.
    Fournier P; Wilden H; Schirrmacher V
    Int J Oncol; 2012 Jan; 40(1):287-98. PubMed ID: 21971670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity.
    Fournier P; Arnold A; Wilden H; Schirrmacher V
    Int J Oncol; 2012 Mar; 40(3):840-50. PubMed ID: 22102168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
    Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
    Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.
    Ayithan N; Bradfute SB; Anthony SM; Stuthman KS; Dye JM; Bavari S; Bray M; Ozato K
    J Interferon Cytokine Res; 2014 Feb; 34(2):79-89. PubMed ID: 24102579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune evasion in ebolavirus infections.
    Audet J; Kobinger GP
    Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.
    Ayithan N; Bradfute SB; Anthony SM; Stuthman KS; Bavari S; Bray M; Ozato K
    PLoS One; 2015; 10(2):e0118345. PubMed ID: 25719445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
    Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
    Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type-specific involvement of RIG-I in antiviral response.
    Kato H; Sato S; Yoneyama M; Yamamoto M; Uematsu S; Matsui K; Tsujimura T; Takeda K; Fujita T; Takeuchi O; Akira S
    Immunity; 2005 Jul; 23(1):19-28. PubMed ID: 16039576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type-specific innate immune response to oncolytic Newcastle disease virus.
    Biswas M; Kumar SR; Allen A; Yong W; Nimmanapalli R; Samal SK; Elankumaran S
    Viral Immunol; 2012 Aug; 25(4):268-76. PubMed ID: 22808996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of host immune responses in Ebola virus infections.
    Wong G; Kobinger GP; Qiu X
    Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
    Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filoviral immune evasion mechanisms.
    Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
    Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interferon gamma by a highly virulent strain of Newcastle disease virus decreases its pathogenicity in chickens.
    Susta L; Cornax I; Diel DG; Garcia SC; Miller PJ; Liu X; Hu S; Brown CC; Afonso CL
    Microb Pathog; 2013; 61-62():73-83. PubMed ID: 23711962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune evasion by filoviruses.
    Basler CF
    Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goose RIG-I functions in innate immunity against Newcastle disease virus infections.
    Sun Y; Ding N; Ding SS; Yu S; Meng C; Chen H; Qiu X; Zhang S; Yu Y; Zhan Y; Ding C
    Mol Immunol; 2013 Apr; 53(4):321-7. PubMed ID: 23063767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus.
    Wilden H; Schirrmacher V; Fournier P
    Int J Oncol; 2011 Aug; 39(2):493-504. PubMed ID: 21567079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
    Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
    J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigeon RIG-I Function in Innate Immunity against H9N2 IAV and IBDV.
    Xu W; Shao Q; Zang Y; Guo Q; Zhang Y; Li Z
    Viruses; 2015 Jul; 7(7):4131-51. PubMed ID: 26205406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.